SNPs in disease gene mapping, medicinal drug development and evolution

Area of Science:

• Genetics
• Evolutionary Biology
• Pharmacogenomics

Background:

• Single nucleotide polymorphisms (SNPs) are key genetic variations influencing human health and drug responses.
• Understanding SNPs aids in identifying disease-associated genes and inter-individual variability in medication efficacy.
• SNPs are also crucial for studying the molecular mechanisms underlying sequence evolution.

Purpose of the Study:

• To explore the role of SNPs in identifying disease-causing genes.
• To investigate the association between genetic makeup, drug response, and personalized medicine development.
• To understand the relationship between SNPs, nucleotide substitution patterns, and evolutionary selection pressures.

Main Methods:

• Analysis of single nucleotide polymorphism (SNP) technologies.
• Association studies linking genetic variations to disease and drug response.
• Examination of nucleotide substitution rates, types, and selection pressures across genes.

Main Results:

• SNPs can identify disease-causing genes and predict individual drug responses, enabling personalized medicine.
• Non-uniform rates and types of nucleotide substitutions, along with varying selection pressures, are observed within genes.
• Residues under strong selective pressure correlate significantly with human diseases, indicating natural selection's role.

Conclusions:

• SNP analysis holds significant potential for advancing personalized medicine and improving drug safety and efficacy.
• The study highlights the intricate relationship between evolutionary processes, genetic variations like SNPs, and the manifestation of human diseases.
• Deleterious mutations are generally removed by natural selection, while advantageous or neutral mutations may become fixed, influencing disease pathology.